| Outgoing Relation(s) |
| EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) is a EC 3.1.1.* (carboxylic ester hydrolase) inhibitor (CHEBI:76773) |
| Incoming Relation(s) |
| N-(p-amylcinnamoyl)anthranilic acid (CHEBI:139349) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| trans-benzylideneacetone (CHEBI:78399) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| 1-(all-cis-docosa-7,10,13,16-tetraenoyl)glycerol (CHEBI:142499) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| AACOCF3 (CHEBI:2341) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| alminoprofen (CHEBI:31190) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| berberine (CHEBI:16118) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| dysidine (CHEBI:65816) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| manoalide (CHEBI:66666) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| ochnaflavone (CHEBI:194126) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| papyriflavonol A (CHEBI:66727) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| scalaradial (CHEBI:67731) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| thioetheramide PC (CHEBI:27712) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| varespladib (CHEBI:189668) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
| varespladib methyl (CHEBI:192805) has role EC 3.1.1.4 (phospholipase A2) inhibitor (CHEBI:50469) |
